New drug that halves cancer recurrence risk to be offered by NHS

AdobeStock_181493676

NHS England is to roll out a new drug which halves the risk of cancer for patients dealing with a return of the disease after undergoing treatment

Please register to continue reading this content

Guidelines is completely free for all UK-based healthcare professionals